Pancreatic Cancer Research

ResearcherUniversity of AntwerpActive in the last 2 years

Timon Vandamme

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3701-5305; OpenAlex author ID A5059566426. Sources: ClinicalTrials.gov.

Their work

Papers
5 (first author 1, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 3 papers, 1 trial · 2024: none · 2025: 1 paper

Papers 5

  1. Stereotactic body radiation therapy for inoperable non-metastasized pancreatic adenocarcinoma: a randomised phase II study (TORPEDO). First author DOI 10.1186/s12885-025-15041-8↗
  2. Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer. Co-author DOI 10.1038/s41698-023-00480-y↗
  3. Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy. Co-author DOI 10.1080/14737140.2023.2270161↗
  4. Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline rese… Co-author DOI 10.1186/s12885-023-11327-x↗
  5. Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. Co-author DOI 10.3390/cancers13050987↗

Trials 1

  1. First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients Principal investigator NCT05964361↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marc Peeters · 3 shared papers, 2021–2023 · strength 0.47
  2. Geert Roeyen · 3 shared papers, 2021–2025 · strength 0.45
  3. Christelle Bouchart · 2 shared papers, 2023–2025 · strength 0.37
  4. Christophe Deben · 2 shared papers, 2021–2023 · strength 0.26
  5. Hans Prenen · 2 shared papers, 2021–2023 · strength 0.26
  6. Evelien Smits · 2 shared papers, 2021–2023 · strength 0.26
  7. Andreas Domen · 2 shared papers, 2021–2023 · strength 0.26
  8. Timothy Jay Price · 1 shared paper, 2023 · strength 0.20
  9. Barbara Geerinckx · 1 shared paper, 2023 · strength 0.20
  10. Daan Stas · 1 shared paper, 2025 · strength 0.19
  11. Ines Joye · 1 shared paper, 2025 · strength 0.19
  12. Julie Navez · 1 shared paper, 2023 · strength 0.18
  13. Jean Closset · 1 shared paper, 2023 · strength 0.18
  14. Pieter Demetter · 1 shared paper, 2023 · strength 0.18
  15. Jean‐Luc Van Laethem · 1 shared paper, 2023 · strength 0.18
  16. Karen Paula Geboes · 1 shared paper, 2023 · strength 0.18
  17. Sofía L. J. Peeters · 1 shared paper, 2023 · strength 0.15
  18. Maxim Le Compte · 1 shared paper, 2023 · strength 0.15
  19. Delphine Quatannens · 1 shared paper, 2021 · strength 0.11
  20. Jonas R.M. Van Audenaerde · 1 shared paper, 2021 · strength 0.11
  21. Sara R. Zanivan · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.